Fort Sheridan Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Fort Sheridan Advisors's BSX Position: Q2 2026 in Review
Fort Sheridan Advisors reduced its Boston Scientific (BSX) stake by 14% in Q2 2026, selling an estimated $135K and leaving 15,474 shares worth $660K. The position accounts for 0.07% of the portfolio, ranked #157.
Fort Sheridan Advisors first reported a position in BSX in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.87M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Fort Sheridan Advisors held 15,474 shares of Boston Scientific worth $660K as of Q2 2026.
- Fort Sheridan Advisors sold 2,482 Boston Scientific shares in Q2 2026, an estimated $135K.
- Boston Scientific made up 0.07% of Fort Sheridan Advisors's portfolio in Q2 2026, its #157 holding.
- Fort Sheridan Advisors first reported a position in Boston Scientific in Q3 2021 and has held it in 20 quarters since.
- Fort Sheridan Advisors's Boston Scientific position peaked at $1.87M in Q2 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Fort Sheridan Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.